Orthofix Medical (NASDAQ:OFIX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.68) by 80.88 percent. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $196.700 million which beat the analyst consensus estimate of $193.985 million by 1.40 percent. This is a 1.58 percent increase over sales of $193.646 million the same period last year.